Featured Research

from universities, journals, and other organizations

Discovery Of The Cellular Origin Of Ewing's Sarcoma

Date:
May 21, 2007
Source:
Curie Institute
Summary:
Scientists have identified the cells that cause Ewing's sarcoma. They are cells of the mesenchyme, the connective tissue that supports other tissues. The researchers have also succeeded in transforming the tumor cells into virtually normal mesenchymal cells again. These results open up new therapeutic possibilities for blocking the development of Ewing's sarcoma in young patients.

When cells learn (again) to make fat... These are cells from a Ewing's sarcoma. The abnormal protein EWS/FLI-1, which causes Ewing's sarcoma, has been inhibited in the cells on the right, but not in those on the left. Under conditions that induce differentiation (line at bottom), only tumor cells in which EWS/FLI1 has been inhibited (bottom right) produce lipid vesicles (stained in red), which show that they have become (again) fat cells. The tumor cells have been "forced" to return to their original status.
Credit: Copyright Franck Tirode/Inserm/Institut Curie

Inserm researchers at the Institut Curie have identified the cells that cause Ewing’s sarcoma. They are cells of the mesenchyme, the connective tissue that supports other tissues. The Institut Curie is the reference center in France for Ewing’s sarcoma, a bone tumor of children, adolescents, and young adults. The researchers have also succeeded “to make” the tumor cells to become virtually normal mesenchymal cells again. These results open up new therapeutic possibilities for blocking the development of Ewing’s sarcoma in young patients.

Ewing’s sarcoma (cancer of the connective tissue) is the second most frequent malignant bone tumor in France, with 50 to 100 new cases a year. It occurs in children, teenagers, and young adults (up to 30 years of age), at a frequency that peaks around puberty, between 10 and 20 years of age. This bone tumor essentially grows in the pelvis, ribs, femur, fibula, and tibia. It is highly invasive and metastases are common, especially in the lungs and skeleton.

Treatment of Ewing’s sarcoma, has progressed greatly in the last thirty years. Nowadays, the therapeutic strategy used in most cases combines chemotherapy, radiotherapy and surgery. The Institut Curie is the reference center for Ewing’s sarcoma in France, and is internationally renowned both for clinical management of patients and research into this disease.

New therapeutic leads

Cancers rarely have a simple molecular signature—a specific mutation that causes tumor growth. In the case of Ewing’s sarcoma, a molecular signature was identified and characterized in 1992 by Olivier Delattre’s Inserm team at the Institut Curie. It is an accidental change of genetic material between two chromosomes, which results in the formation of a mutant gene, which codes for an abnormal protein called EWS/FLI-1. This discovery led on to the development of a diagnostic test for Ewing’s sarcoma in 1994.

Yet until now, the nature of the cell in which this mutation occurs was unknown.

The group of Olivier Delattre, the Director of Inserm Unit 830 “Genetics and Biology of Cancer” at the Institut Curie, and the team of Pierre Charbord, the Director of Inserm Laboratory ERI5 “Microenvironment of Hematopoiesis and Stem Cells” in Tours, have now discovered that Ewing’s sarcoma are caused by cells of the mesenchyme, a connective tissue that supports other tissues. They have shown that the profile of the transcriptome* of Ewing’s sarcoma ressemble that of mesenchymal cells, particularly mesenchymal stem cells, when EWS/FLI-1 is inhibited.

By inhibiting the abnormal protein EWS/FLI-1 that causes Ewing’s sarcoma, the researchers also “forced” the tumor cells to return to their original status of mesenchymal stem cells, which can then differentiate normally into bone or fat cells. This approach opens up new therapeutic prospects, since by forcing the cells to resume their original function it may be possible in the future to make them less aggressive and prevent their proliferation. As long as the tumor cells are still able to fulfill their function, they generally proliferate slowly, and the prognosis is good; once they lose this capacity, however, the tumor cells become highly aggressive.

This discovery could allow Delattre, Charbord and colleagues to produce an animal model of Ewing’s sarcoma, an essential stage in the development of new treatments. These results were published in the May 7 issue of Cancer Cell.

*The transcriptome comprises all of a cell’s messenger RNA, which carries information from part of the genome for the synthesis of proteins.


Story Source:

The above story is based on materials provided by Curie Institute. Note: Materials may be edited for content and length.


Cite This Page:

Curie Institute. "Discovery Of The Cellular Origin Of Ewing's Sarcoma." ScienceDaily. ScienceDaily, 21 May 2007. <www.sciencedaily.com/releases/2007/05/070519152605.htm>.
Curie Institute. (2007, May 21). Discovery Of The Cellular Origin Of Ewing's Sarcoma. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2007/05/070519152605.htm
Curie Institute. "Discovery Of The Cellular Origin Of Ewing's Sarcoma." ScienceDaily. www.sciencedaily.com/releases/2007/05/070519152605.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins